160 related articles for article (PubMed ID: 12163492)
1. Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells.
Béranger F; Mangé A; Goud B; Lehmann S
J Biol Chem; 2002 Oct; 277(41):38972-7. PubMed ID: 12163492
[TBL] [Abstract][Full Text] [Related]
2. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
3. Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway.
Massignan T; Biasini E; Lauranzano E; Veglianese P; Pignataro M; Fioriti L; Harris DA; Salmona M; Chiesa R; Bonetto V
Mol Cell Proteomics; 2010 Apr; 9(4):611-22. PubMed ID: 19996123
[TBL] [Abstract][Full Text] [Related]
4. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of nonconvertible PrPc delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation.
Hölscher C; Delius H; Bürkle A
J Virol; 1998 Feb; 72(2):1153-9. PubMed ID: 9445012
[TBL] [Abstract][Full Text] [Related]
6. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.
Cardinale A; Filesi I; Vetrugno V; Pocchiari M; Sy MS; Biocca S
J Biol Chem; 2005 Jan; 280(1):685-94. PubMed ID: 15513919
[TBL] [Abstract][Full Text] [Related]
7. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking.
Sakaguchi S; Uchiyama K
Prion; 2017 Nov; 11(6):398-404. PubMed ID: 29099278
[TBL] [Abstract][Full Text] [Related]
8. Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells.
Shim SY; Karri S; Law S; Schatzl HM; Gilch S
Sci Rep; 2016 Feb; 6():21658. PubMed ID: 26865414
[TBL] [Abstract][Full Text] [Related]
9. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.
Nunziante M; Ackermann K; Dietrich K; Wolf H; Gädtke L; Gilch S; Vorberg I; Groschup M; Schätzl HM
J Biol Chem; 2011 Sep; 286(39):33942-53. PubMed ID: 21835918
[TBL] [Abstract][Full Text] [Related]
10. Identification of an intracellular site of prion conversion.
Marijanovic Z; Caputo A; Campana V; Zurzolo C
PLoS Pathog; 2009 May; 5(5):e1000426. PubMed ID: 19424437
[TBL] [Abstract][Full Text] [Related]
11. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
12. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
Norstrom EM; Mastrianni JA
J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
[TBL] [Abstract][Full Text] [Related]
13. Characterization of prion susceptibility in Neuro2a mouse neuroblastoma cell subclones.
Uryu M; Karino A; Kamihara Y; Horiuchi M
Microbiol Immunol; 2007; 51(7):661-9. PubMed ID: 17641468
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of quality control proteins reduces prion conversion in prion-infected cells.
Thapa S; Abdulrahman B; Abdelaziz DH; Lu L; Ben Aissa M; Schatzl HM
J Biol Chem; 2018 Oct; 293(41):16069-16082. PubMed ID: 30154245
[TBL] [Abstract][Full Text] [Related]
15. Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum.
Campana V; Sarnataro D; Fasano C; Casanova P; Paladino S; Zurzolo C
J Cell Sci; 2006 Feb; 119(Pt 3):433-42. PubMed ID: 16443748
[TBL] [Abstract][Full Text] [Related]
16. The highways and byways of prion protein trafficking.
Campana V; Sarnataro D; Zurzolo C
Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
[TBL] [Abstract][Full Text] [Related]
17. Trafficking, turnover and membrane topology of PrP.
Harris DA
Br Med Bull; 2003; 66():71-85. PubMed ID: 14522850
[TBL] [Abstract][Full Text] [Related]
18. Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP
Hiller H; Yang C; Beachy DE; Kusmartseva I; Candelario-Jalil E; Posgai AL; Nick HS; Schatz D; Atkinson MA; Wasserfall CH
Diabetologia; 2021 Oct; 64(10):2279-2291. PubMed ID: 34274990
[TBL] [Abstract][Full Text] [Related]
19. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
Filesi I; Cardinale A; Mattei S; Biocca S
J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
[TBL] [Abstract][Full Text] [Related]
20. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein.
Hetz C; Russelakis-Carneiro M; Maundrell K; Castilla J; Soto C
EMBO J; 2003 Oct; 22(20):5435-45. PubMed ID: 14532116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
